Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fluidigm single-cell RNA-seq analysis for gene signatures associated with T-cell persistence

ABSTRACT: Fluidigm single-cell RNA-seq analysis for gene signatures associated with T-cell persistence

PROVIDER: PRJNA562867 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10035100_1.fastq.gz	Fastqsanger.gz
	SRR10035100_2.fastq.gz	Fastqsanger.gz
	SRR10035200_1.fastq.gz	Fastqsanger.gz
	SRR10035200_2.fastq.gz	Fastqsanger.gz
	SRR10035101_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 442

Similar Datasets

Fluidigm single-cell RNA-seq analysis for gene signatures associated with T-cell persistence

2020-08-28 | GSE136610 | GEO

Single-cell transcriptome analysis reveals gene signatures associated with T-cell persistence following adoptive cell therapy

Project description:Single-cell transcriptome analysis reveals gene signatures associated with T-cell persistence following adoptive cell therapy

| PRJNA562473 | ENA

Single-cell transcriptome analysis reveals gene signatures associated with T-cell persistence following adoptive cell therapy

Project description:A patient (4095) with metastatic colorectal cancer was treated with polyclonal tumor infiltrating lymphocytes (TILs) targeting the KRAS(G12D) hotspot mutation. Three dominant clonotypes specifically recognizing KRAS(G12D) epitopes were identified, but we found that only two clonotypes persisted 40 days after TIL treatment. Because of these findings, in this study, we utilized a 10X system to perform single-cell TCR/transcriptome analysis for the TILs isolated from this patient, together with 4 additional TILs isolated from 4 patients (4007, 4069, 4071, 4081) treated within 5-month window. In addition, we performed single-cell TCR/transcriptome analysis on Patient 4095's peripheral blood lymphocytes (PBL) day 12 or day 40 after TIL treatment. We also utilized a low-throughput Fluidigm C1 system to perform single-cell RNA-Seq on TIL4095. Please use accession number GSE136610 to find the dataset.

2019-09-10 | GSE136394 | GEO

Preparing for the first breath at single cell level [single cell Fluidigm C1]

Project description:Preparing for the first breath at single cell level [single cell Fluidigm C1]

| PRJNA504644 | ENA

Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells

Project description:This study provides an assessment of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells. The system combines microfluidic technology and nanoliter-scale reactions. We sequenced 622 cells allowing identification of 341 islet cells with high-quality gene expression profiles. The cells clustered into populations of alpha-cells (5%), beta-cells (92%), delta-cells (1%) and PP-cells (2%). We identified cell-type specific transcription factors and pathways primarily involved in nutrient sensing and oxidation and cell signaling. Unexpectedly, 281 cells had to be removed from the analysis due to low viability (23%), low sequencing quality (13%) or contamination resulting in the detection of more than one islet hormone (64%). Collectively, we provide a resource for identification of high-quality gene expression datasets to help expand insights into genes and pathways characterizing islet cell types. We reveal limitations in the C1 Fluidigm cell capture process resulting in contaminated cells with altered gene expression patterns. This calls for caution when interpreting single-cell transcriptomics data using the C1 Fluidigm system. Single-cell RNA sequencing of mouse C57BL/6 pancreatic islet cells

2016-02-19 | E-GEOD-77980 | biostudies-arrayexpress

A cost effective single cell RNA sequencing approach for the Fluidigm C1

Project description:A cost effective single cell RNA sequencing approach for the Fluidigm C1

| PRJNA315001 | ENA

Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells

2016-02-19 | GSE77980 | GEO

Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy.

Project description:Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) can mediate responses in some patients with metastatic epithelial cancer. Identifying gene signatures associated with successful ACT might enable the development of improved therapeutic approaches. The persistence of transferred T cells in the peripheral blood is one indication of clinical effectiveness, but many T-cell and host factors may influence T-cell persistence. To limit these variables, we previously studied a patient with metastatic colorectal cancer treated with polyclonal TILs targeting the KRAS(G12D) hotspot mutation, who experienced a partial response for 9 months. Three dominant clonotypes specifically recognizing KRAS(G12D) epitopes were identified, but we found that only two clonotypes persisted 40 days after ACT. Because of these findings, in this study, we performed the single-cell transcriptome analysis of the infused TILs. The analysis revealed a total of 472 genes that were differentially expressed between clonotypes 9.1-NP and 9.2-P single cells, and 528 genes between 9.1-NP and 10-P. Following these clonotypes in the peripheral blood after ACT, the gene expression patterns changed, but IL7R, ITGB1, KLF2, and ZNF683 remained expressed in the persistent 9.2-P and 10-P cells, compared with the nonpersistent 9.1-NP cells. In addition, four autologous TILs, which were used for treatment but persisted poorly 1 month after ACT, did not express the gene profiles associated with persistence. These results suggest that certain TIL populations possess a unique gene expression profile that can lead to the persistence of T cells. Thus, this single-patient study provides insight into how to improve ACT for solid cancer.

| S-EPMC6825592 | biostudies-literature

Single cell RNA seq of adult mouse mammary gland using Fluidigm C1 platform.

Project description:Single cell RNA seq of adult mouse mammary gland using Fluidigm C1 platform.

| PRJNA650512 | ENA

Listeria Persistence

Project description:Listeria Persistence

| PRJEB1355 | ENA